Late-onset Sepsis in Term and Pre-term Neonates and Infants up to 3 Months of Age

Clinical trial NCT05856227 · COMPLETED

Trial details

NCT number: NCT05856227
Sponsor: Basilea Pharmaceutica
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Neonatal Sepsis

Start date: 2023-08-06
Primary completion: 2024-12-18
Enrollment: 9

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.